Search Results
Results found for "career development"
- 📰 GPCR Weekly News, April 10 to 16, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Engineering NEW Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development
- Drug Discovery Picks Up the Pace, Stays on Target
A project to develop a perfect drug, or a drug that is as safe and effective as possible, may never begin
- G protein-coupled receptor kinase 2 is essential to enable vasoconstrictor-mediated arterial ...
signalling pathways that promote vascular smooth muscle cell (VSMC) proliferation, contributing to the development Considering VSMC GRK2 expression increases early in the development of hypertension, this highlights
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
artificial intelligence (AI), machine learning, and the design of protein structures in the discovery and development
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Redefine Your Pipeline If your development program is built around potency alone, you may be leaving
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
G-protein-coupled receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
regarding the complex biology of the preproglucagon-derived hormones, their signaling, and the drug development
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
The effect of CCL25 on the development of SACC in vivo was examined by a xenograft tumor model in nude
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
regulating proliferation, inflammation, adhesion, migration, insulin release, muscle relaxation, and cancer development
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Addex Raises $10 Million In Equity Financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- 📰 GPCR Weekly News, April 24 to 30, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Antibody Engineering Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development
- Therapeutic validation of an orphan G protein‐coupled receptor
shown to play key roles in various physiological functions, such as sensory perception, reproduction, development From these series of compounds, GLPG1205 progressed into clinical development for the potential treatment
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
These insights will facilitate further development of therapeutic agents targeting the DOR.Communicated
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
in structural biological advancements of GPCRs and design of thermally stabilized receptors for drug development
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Ligand-directed labelling strategies are a newly developed way to attach a fluorescent tag to a GPCR
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
Because Tag-lite® is based on FRET, we have collaborated with BMG Labtech to develop an application note
- Radioligands vs. Fluorescent Ligands: Binding Assays
design for specific targets: Not all targets have available high-affinity radioligands, but with the development
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
library for its industry-leading biology platform to identify potential GPCR targets and advance the development
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
pharmacologists misinterpret how an antagonist interacts with its receptor, the consequences ripple across assay development
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
receptors "Recently, academic and industrial scientific communities involved in kinetics-based drug development
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
conformation of the receptor and consequently activated signaling pathways, and also may shed light on the development
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- Addex raises $4.2 million in equity financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
translational medicine capabilities • ‘Venture-like’ capital allocation approach to focus pipeline development
- Adhesion GPCR Consortium Newsletter - May 2024
understand how aGPCR works but might also provide a guide to how pharmacological approaches will be developed among the aGPCR community, added to the fact that this will all take place for the first time in a developing
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
impact of cannabis or its components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on MG development






